INmune Bio Q3 EPS $(0.17) Misses $(0.15) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 29.17 percent increase over losses of $(0.24) per share from the
INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 29.17 percent increase over losses of $(0.24) per share from the same period last year.